• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】31018

【品名】tert-butyl (3R,4R)-3-hydroxy-4-(4-[3-[(2-methoxybenzyl)oxy]propoxy]phenyl)-1-piperidinecarboxylate

【CA登记号】

【 分 子 式 】C27H37NO6

【 分 子 量 】471.59392

【元素组成】C 68.77% H 7.91% N 2.97% O 20.36%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(XII)

The condensation of 1-benzyl-4-piperidone (I) with 4-iodoanisole (II) in ethyl ether gives 1-benzyl-4-(2-methoxyphenyl)piperidin-4-ol (III), which is dehydrated by means of p-toluenesulfonic acid in refluxing toluene yielding the tetrahydropyridine (IV). The hydroboration of (IV) with NaBH4 and BF3 ethearate in dimethoxyethane affords trans-1-benzyl-4-(2-methoxyphenyl)piperidin-3-ol (V), which is treated with BBr3 in dichloromethane to give the 4-hydroxyphenyl derivative (VI). The hydrogenolysis of (VI) with H2 over Pd/C in methanol yields trans-4-(2-hydroxyphenyl)piperidin-3-ol (VII), which is treated with tert-butoxycarbonyl anhydride and triethylamine in DMF to afford the carbamate (VIII). The condensation of 3-chloropropyl-(2-methoxyphenyl)ether (IX) (obtained by the NaH promoted condensation of 2-methoxybenzyl chloride (X) and 3-chloropropanol (XI)) with (VIII) by means of K2CO3 in hot 2-butanone gives the expected phenolic ether (XII), which is condensed with 7-(bromomethyl)quinoline (XIII) by means of NaH in DMF yielding the piperidinyl ether (XIV). The selective hydrogenation of (XIV) with NiCl2 and NaBH4 in methanol affords the tetrahydroquinoline derivative (XV), which is finally treated with HCl in methanol to eliminate the carbamate protecting group.

1 Breu, V.; Guller, R.; Binggeli, A.; et al.; Piperidine-renin inhibitors compounds with improved physicochemical properties. Bioorg Med Chem Lett 1999, 9, 10, 1403.
2 Binggeli, A.; Breu, V.; Bur, D.; Fischli, W.; Gueller, R.; Hirth, G.; Maerki, H.-P.; Mueller, M.; Oefner, C.; Stadler, H.; Vieira, E.; Wilhelm, M.; Wostl, W. (F. Hoffmann-La Roche AG); New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency. EP 0863875; JP 1999500447; WO 9709311 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15720 1-benzyltetrahydro-4(1H)-pyridinone; 1-Benzyl-4-piperidone; N-Benzyl-4-piperidone; 1-(benzyl)-4-piperidinone; 1-benzylpiperidin-4-one; 1-(benzyl)piperidin-4-one 3612-20-2 C12H15NO 详情 详情
(II) 31009 1-iodo-4-methoxybenzene; 4-iodophenyl methyl ether 696-62-8 C7H7IO 详情 详情
(III) 31010 4-(1-benzyl-4-methyl-4-piperidinyl)phenyl methyl ether; 1-benzyl-4-(4-methoxyphenyl)-4-methylpiperidine C20H25NO 详情 详情
(IV) 31011 4-(1-benzyl-1,2,3,6-tetrahydro-4-pyridinyl)phenyl methyl ether; 1-benzyl-4-(4-methoxyphenyl)-1,2,3,6-tetrahydropyridine C19H21NO 详情 详情
(V) 31012 (3R,4R)-1-benzyl-4-(4-methoxyphenyl)-3-piperidinol C19H23NO2 详情 详情
(VI) 31013 (3R,4R)-1-benzyl-4-(4-hydroxyphenyl)-3-piperidinol C18H21NO2 详情 详情
(VII) 31014 (3R,4R)-4-(4-hydroxyphenyl)-3-piperidinol C11H15NO2 详情 详情
(VIII) 31015 tert-butyl (3R,4R)-3-hydroxy-4-(4-hydroxyphenyl)-1-piperidinecarboxylate C16H23NO4 详情 详情
(IX) 31016 1-[(3-chloropropoxy)methyl]-2-methoxybenzene; 2-[(3-chloropropoxy)methyl]phenyl methyl ether C11H15ClO2 详情 详情
(X) 31017 2-(chloromethyl)phenyl methyl ether; 1-(chloromethyl)-2-methoxybenzene 7035-02-1 C8H9ClO 详情 详情
(XI) 19490 3-chloro-1-propanol 627-30-5 C3H7ClO 详情 详情
(XII) 31018 tert-butyl (3R,4R)-3-hydroxy-4-(4-[3-[(2-methoxybenzyl)oxy]propoxy]phenyl)-1-piperidinecarboxylate C27H37NO6 详情 详情
(XIII) 31019 7-(bromomethyl)quinoline C10H8BrN 详情 详情
(XIV) 31020 tert-butyl (3R,4R)-4-(4-[3-[(2-methoxybenzyl)oxy]propoxy]phenyl)-3-(7-quinolinylmethoxy)-1-piperidinecarboxylate C37H44N2O6 详情 详情
(XV) 31021 tert-butyl (3R,4R)-4-(4-[3-[(2-methoxybenzyl)oxy]propoxy]phenyl)-3-(1,2,3,4-tetrahydro-7-quinolinylmethoxy)-1-piperidinecarboxylate C37H48N2O6 详情 详情
Extended Information